Hard to Treat Diseases Inc. (HTDS)

OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Feb 27, 2026
0.00%
Market Cap 5.82K
Revenue (ttm) 6.16M
Net Income (ttm) 974.30K
Shares Out 5.82B
EPS (ttm) 0.00
PE Ratio 0.01
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 704,998
Average Volume 1,628,928
Open 0.0000
Previous Close 0.0000
Day's Range 0.0000 - 0.0000
52-Week Range n/a
Beta 0.56
RSI 51.46
Earnings Date n/a

About Hard to Treat Diseases

Hard to Treat Diseases Inc. manufactures, supplies, and exports human vaccines and biological products in China and internationally. The company offers human vaccines, such as recombinant human papillomavirus bivalent, freeze-dried live attenuated hepatitis A, recombinant hepatitis E, meningococcal polysaccharide, 23-valent pneumococcal polysaccharide, varicella, rabies, group ACYW135meningococcal conjugate, inactivated poliomyelitis, enterovirus Type 71, influenza, meningococcal Group A, C bivalent polysaccharide conjugate, recombinant hepatit... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Country United States
Stock Exchange OTCMKTS
Ticker Symbol HTDS
Full Company Profile

Financial Performance

News

There is no news available yet.